• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INTELLANAV STABLEPOINT; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER Back to Search Results
Model Number M004RFSDS96200
Medical Device Problem Code Impedance Problem (2950)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/31/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the device had an impedance issue and subsequently the procedure was cancelled.During an ablation procedure to treat atrial fibrillation/flutter, an intellanav stablepoint catheter was selected for use.The catheter was inserted into the right atrium, connections were all good.When radiofrequency was started, there was no impedance drop despite having 20 grams or more of contact force and a grounding pad on the patient's thigh.(starting impedance was around 150.) trouble shooting was performed; the connections were disconnected and re-connected and a signal displayed on the system.The flow rate of the catheter was changed from 30ml to 17ml, but the issue persisted.Due to no impedance drop, the physician chose to discontinue the procedure.There were no patient complications.The device is expected to be returned for analysis.This is being reported for procedure cancellation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTELLANAV STABLEPOINT
Common Device Name
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FLUTTER
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
302 parkway, global park
la aurora - heredia
CS  
Manufacturer Contact
mary crawford
4100 hamline avenue north
dc a330
saint paul, MN 55112
6514400979
MDR Report Key21459879
Report Number2124215-2025-11370
Device Sequence Number7641753
Product Code OAD
UDI-Device Identifier08714729992233
UDI-Public08714729992233
Combination Product (Y/N)N
Initial Reporter StateMA
Initial Reporter CountryUS
PMA/510(K) Number
P150005
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 02/25/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date03/01/2026
Device Model NumberM004RFSDS96200
Device Catalogue NumberM004RFSDS96200
Device Lot Number0033542178
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/19/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/31/2025
Initial Report FDA Received Date02/25/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured03/01/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-